Similarly in breast cancer, expression of PAX2 has been associated with a low invasive phenotype in luminal breast cancer cells [54], while in endometrial cancer joint loss of PAX2 and PTEN expression was associated with progression to carcinoma [55]. The gene discussed is PTEN; the disease is carcinoma.